Fluoroquinolone Resistance in Campylobacter jejuni Isolates in Travelers Returning to Finland: Association of Ciprofloxacin Resistance to Travel Destination

Ciprofloxacin resistance was analyzed in 354 Campylobacter jejuni isolates collected during two study periods (1995–1997 and 1998–2000) from travelers returning to Finland. The increase in resistance between the two periods was significant among all isolates (40% vs. 60%; p<0.01), as well as among those from Asia alone (45% vs. 72%; p<0.01).

[1]  A. Siitonen,et al.  Quality Control Strains Used in Susceptibility Testing of Campylobacter spp.   , 2002, Journal of Clinical Microbiology.

[2]  A. Siitonen,et al.  Reduced fluoroquinolone susceptibility in Salmonella enterica serotypes in travelers returning from Southeast Asia. , 2001, Emerging infectious diseases.

[3]  J. Ruiz,et al.  Increased Resistance to Quinolones in Campylobacter jejuni: A Genetic Analysis of gyrA Gene Mutations in Quinolone‐Resistant Clinical Isolates , 1998, Microbiology and immunology.

[4]  C. Hoge,et al.  Trends in antibiotic resistance among diarrheal pathogens isolated in Thailand over 15 years. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  A. Serra,et al.  Susceptibilities to 10 antimicrobial agents of 1,220 Campylobacter strains isolated from 1987 to 1993 from feces of pediatric patients , 1994, Antimicrobial Agents and Chemotherapy.

[6]  E. Bouza,et al.  Evolution of susceptibilities of Campylobacter spp. to quinolones and macrolides , 1994, Antimicrobial Agents and Chemotherapy.

[7]  C. Gaudreau,et al.  Susceptibility of clinical isolates of Campylobacter jejuni to twenty-five antimicrobial agents. , 1986, The Journal of antimicrobial chemotherapy.

[8]  R. Petrak,et al.  Comparative in vitro activities of twelve antimicrobial agents against Campylobacter species , 1985, Antimicrobial Agents and Chemotherapy.

[9]  F. Aarestrup,et al.  Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates. , 2001, Emerging infectious diseases.